Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.

JCI insight

Kienhöfer D, Hahn J, Stoof J, Csepregi JZ, Reinwald C, Urbonaviciute V, Johnsson C, Maueröder C, Podolska MJ, Biermann MH, Leppkes M, Harrer T, Hultqvist M, Olofsson P, Munoz LE, Mocsai A, Herrmann M, Schett G, Holmdahl R, Hoffmann MH.
PMID: 28515366
JCI Insight. 2017 May 18;2(10). doi: 10.1172/jci.insight.92920. eCollection 2017 May 18.

Many effector mechanisms of neutrophils have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Neutrophil extracellular traps (NETs) have been assigned a particularly detrimental role. Here we investigated the functional impact of neutrophils and NETs on a...

Cite
Kienhöfer D, Hahn J, Stoof J, et al. Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight. 2017;2(10)doi: 10.1172/jci.insight.92920.
Kienhöfer, D., Hahn, J., Stoof, J., Csepregi, J. Z., Reinwald, C., Urbonaviciute, V., Johnsson, C., Maueröder, C., Podolska, M. J., Biermann, M. H., Leppkes, M., Harrer, T., Hultqvist, M., Olofsson, P., Munoz, L. E., Mocsai, A., Herrmann, M., Schett, G., Holmdahl, R., & Hoffmann, M. H. (2017). Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI insight, 2(10), . https://doi.org/10.1172/jci.insight.92920
Kienhöfer, Deborah, et al. "Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps." JCI insight vol. 2,10 (2017). doi: https://doi.org/10.1172/jci.insight.92920
Kienhöfer D, Hahn J, Stoof J, Csepregi JZ, Reinwald C, Urbonaviciute V, Johnsson C, Maueröder C, Podolska MJ, Biermann MH, Leppkes M, Harrer T, Hultqvist M, Olofsson P, Munoz LE, Mocsai A, Herrmann M, Schett G, Holmdahl R, Hoffmann MH. Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight. 2017 May 18;2(10). doi: 10.1172/jci.insight.92920. eCollection 2017 May 18. PMID: 28515366; PMCID: PMC5436535.
Copy Download .nbib Format: NLM
Torsten Teorell, the teacher and researcher.

Upsala journal of medical sciences

Holmdahl MH.
PMID: 7571165
Ups J Med Sci. 1995;100(1):5-9. doi: 10.3109/03009739509178891.

No abstract available.

Cite
Holmdahl MH. Torsten Teorell, the teacher and researcher. Ups J Med Sci. 1995;100(1):5-9doi: 10.3109/03009739509178891.
Holmdahl, M. H. (1995). Torsten Teorell, the teacher and researcher. Upsala journal of medical sciences, 100(1), 5-9. https://doi.org/10.3109/03009739509178891
Holmdahl, M H. "Torsten Teorell, the teacher and researcher." Upsala journal of medical sciences vol. 100,1 (1995): 5-9. doi: https://doi.org/10.3109/03009739509178891
Holmdahl MH. Torsten Teorell, the teacher and researcher. Ups J Med Sci. 1995;100(1):5-9. doi: 10.3109/03009739509178891. PMID: 7571165.
Copy Download .nbib Format: NLM
[A note on supplementary drugs in tuberculosis].

Svenska lakartidningen

HOLMDAHL SG.
PMID: 13715450
Sven Lakartidn. 1961 May 05;58:1301-6.

No abstract available.

Cite
HOLMDAHL SG. [A note on supplementary drugs in tuberculosis]. Sven Lakartidn. 1961;58:1301-6
HOLMDAHL, S. G. (1961). [A note on supplementary drugs in tuberculosis]. Svenska lakartidningen, 581301-6.
HOLMDAHL, S G. "[A note on supplementary drugs in tuberculosis]." Svenska lakartidningen vol. 58 (1961): 1301-6.
HOLMDAHL SG. [A note on supplementary drugs in tuberculosis]. Sven Lakartidn. 1961 May 05;58:1301-6. Swedish. PMID: 13715450.
Copy Download .nbib Format: NLM
The programme for premature infants in Gothenburg, Sweden; the principles of treatment and the results obtained.

Acta paediatrica

HOLMDAHL K.
PMID: 14933010
Acta Paediatr. 1952 Jan;41(1):1-14. doi: 10.1111/j.1651-2227.1952.tb17837.x.

No abstract available.

Cite
HOLMDAHL K. The programme for premature infants in Gothenburg, Sweden; the principles of treatment and the results obtained. Acta Paediatr. 1952;41(1):1-14doi: 10.1111/j.1651-2227.1952.tb17837.x.
HOLMDAHL, K. (1952). The programme for premature infants in Gothenburg, Sweden; the principles of treatment and the results obtained. Acta paediatrica, 41(1), 1-14. https://doi.org/10.1111/j.1651-2227.1952.tb17837.x
HOLMDAHL, K. "The programme for premature infants in Gothenburg, Sweden; the principles of treatment and the results obtained." Acta paediatrica vol. 41,1 (1952): 1-14. doi: https://doi.org/10.1111/j.1651-2227.1952.tb17837.x
HOLMDAHL K. The programme for premature infants in Gothenburg, Sweden; the principles of treatment and the results obtained. Acta Paediatr. 1952 Jan;41(1):1-14. doi: 10.1111/j.1651-2227.1952.tb17837.x. PMID: 14933010.
Copy Download .nbib Format: NLM
Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery.

Clinical drug investigation

Bergqvist D, Solhaug JH, Holmdahl L, Eriksson UG, Andersson M, Boberg B, Ogren M.
PMID: 17516699
Clin Drug Investig. 2004;24(3):127-36. doi: 10.2165/00044011-200424030-00001.

OBJECTIVE: The oral direct thrombin inhibitor (oral DTI) ximelagatran and its active form, melagatran, which can be administered subcutaneously, were investigated for the prevention and treatment of thromboembolic complications.DESIGN AND PATIENTS: In this randomised, double-blind, double-dummy, parallel-group study in...

Cite
Bergqvist D, Solhaug JH, Holmdahl L, et al. Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery. Clin Drug Investig. 2004;24(3):127-36doi: 10.2165/00044011-200424030-00001.
Bergqvist, D., Solhaug, J. H., Holmdahl, L., Eriksson, U. G., Andersson, M., Boberg, B., & Ogren, M. (2004). Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery. Clinical drug investigation, 24(3), 127-36. https://doi.org/10.2165/00044011-200424030-00001
Bergqvist, David, et al. "Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery." Clinical drug investigation vol. 24,3 (2004): 127-36. doi: https://doi.org/10.2165/00044011-200424030-00001
Bergqvist D, Solhaug JH, Holmdahl L, Eriksson UG, Andersson M, Boberg B, Ogren M. Pharmacokinetics, preliminary efficacy and safety of subcutaneous melagatran and oral ximelagatran : a multicentre study of thromboprophylaxis in elective abdominal surgery. Clin Drug Investig. 2004;24(3):127-36. doi: 10.2165/00044011-200424030-00001. PMID: 17516699.
Copy Download .nbib Format: NLM
[Care of the premature infant].

Nordisk medicin

SUNDAL A, VON SYDOW G, BRAESTRUP PW, VESTERDAL J, RAIHA CE, AHVENAINEN EK, HOLMDAHL K.
PMID: 13483994
Nord Med. 1957 Aug 29;58(35):1283-92.

No abstract available.

Cite
SUNDAL A, VON SYDOW G, BRAESTRUP PW, et al. Behandling av premature barn. [Care of the premature infant]. Nord Med. 1957;58(35):1283-92
SUNDAL, A., VON SYDOW, G., BRAESTRUP, P. W., VESTERDAL, J., RAIHA, C. E., AHVENAINEN, E. K., & HOLMDAHL, K. (1957). Behandling av premature barn. [Care of the premature infant]. Nordisk medicin, 58(35), 1283-92.
SUNDAL, A, et al. "Behandling av premature barn." [Care of the premature infant]. Nordisk medicin vol. 58,35 (1957): 1283-92.
SUNDAL A, VON SYDOW G, BRAESTRUP PW, VESTERDAL J, RAIHA CE, AHVENAINEN EK, HOLMDAHL K. Behandling av premature barn. [Care of the premature infant]. Nord Med. 1957 Aug 29;58(35):1283-92. Norwegian. PMID: 13483994.
Copy Download .nbib Format: NLM
(18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography.

ACS medicinal chemistry letters

Li XG, Hagert C, Siitonen R, Virtanen H, Sareila O, Liljenbäck H, Tuisku J, Knuuti J, Bergman J, Holmdahl R, Roivainen A.
PMID: 27660685
ACS Med Chem Lett. 2016 May 16;7(9):826-30. doi: 10.1021/acsmedchemlett.6b00160. eCollection 2016 Sep 08.

Recently mannan from Saccharomyces cerevisiae has been shown to be able to induce psoriasis and psoriatic arthritis in mice, and the phenotypes resemble the corresponding human diseases. To investigate the pathological processes, we set out to label mannan with...

Cite
Li XG, Hagert C, Siitonen R, et al. (18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography. ACS Med Chem Lett. 2016;7(9):826-30doi: 10.1021/acsmedchemlett.6b00160.
Li, X. G., Hagert, C., Siitonen, R., Virtanen, H., Sareila, O., Liljenbäck, H., Tuisku, J., Knuuti, J., Bergman, J., Holmdahl, R., & Roivainen, A. (2016). (18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography. ACS medicinal chemistry letters, 7(9), 826-30. https://doi.org/10.1021/acsmedchemlett.6b00160
Li, Xiang-Guo, et al. "(18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography." ACS medicinal chemistry letters vol. 7,9 (2016): 826-30. doi: https://doi.org/10.1021/acsmedchemlett.6b00160
Li XG, Hagert C, Siitonen R, Virtanen H, Sareila O, Liljenbäck H, Tuisku J, Knuuti J, Bergman J, Holmdahl R, Roivainen A. (18)F-Labeling of Mannan for Inflammation Research with Positron Emission Tomography. ACS Med Chem Lett. 2016 May 16;7(9):826-30. doi: 10.1021/acsmedchemlett.6b00160. eCollection 2016 Sep 08. PMID: 27660685; PMCID: PMC5018871.
Copy Download .nbib Format: NLM
Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification.

Computational and structural biotechnology journal

Li X, Zhu W, Fan M, Zhang J, Peng Y, Huang F, Wang N, He L, Zhang L, Holmdahl R, Meng L, Lu S.
PMID: 33850607
Comput Struct Biotechnol J. 2021;19:1933-1943. doi: 10.1016/j.csbj.2021.04.001. Epub 2021 Apr 08.

Coronavirus disease 2019 is a kind of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the mechanism whereby SARS-CoV-2 invades host cells remains poorly understood. Here we used SARS-CoV-2 pseudoviruses to infect human angiotensin-converting enzyme...

Cite
Li X, Zhu W, Fan M, et al. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification. Comput Struct Biotechnol J. 2021;19:1933-1943doi: 10.1016/j.csbj.2021.04.001.
Li, X., Zhu, W., Fan, M., Zhang, J., Peng, Y., Huang, F., Wang, N., He, L., Zhang, L., Holmdahl, R., Meng, L., & Lu, S. (2021). Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification. Computational and structural biotechnology journal, 191933-1943. https://doi.org/10.1016/j.csbj.2021.04.001
Li, Xiaowei, et al. "Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification." Computational and structural biotechnology journal vol. 19 (2021): 1933-1943. doi: https://doi.org/10.1016/j.csbj.2021.04.001
Li X, Zhu W, Fan M, Zhang J, Peng Y, Huang F, Wang N, He L, Zhang L, Holmdahl R, Meng L, Lu S. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification. Comput Struct Biotechnol J. 2021;19:1933-1943. doi: 10.1016/j.csbj.2021.04.001. Epub 2021 Apr 08. PMID: 33850607; PMCID: PMC8028701.
Copy Download .nbib Format: NLM
Autologous full-thickness skin graft as reinforcement in parastomal hernia repair: a randomised controlled trial.

Trials

Holmdahl V, Gunnarsson U, Strigård K.
PMID: 34876195
Trials. 2021 Dec 07;22(1):891. doi: 10.1186/s13063-021-05884-4.

BACKGROUND: Parastomal hernia is a common complication of an enterostomy and can have a significant impact on health-related quality of life. Currently used methods of repair have high recurrence rates and considerable risk for complications. We have developed a...

Cite
Holmdahl V, Gunnarsson U, Strigård K. Autologous full-thickness skin graft as reinforcement in parastomal hernia repair: a randomised controlled trial. Trials. 2021;22(1):891doi: 10.1186/s13063-021-05884-4.
Holmdahl, V., Gunnarsson, U., & Strigård, K. (2021). Autologous full-thickness skin graft as reinforcement in parastomal hernia repair: a randomised controlled trial. Trials, 22(1), 891. https://doi.org/10.1186/s13063-021-05884-4
Holmdahl, Viktor, et al. "Autologous full-thickness skin graft as reinforcement in parastomal hernia repair: a randomised controlled trial." Trials vol. 22,1 (2021): 891. doi: https://doi.org/10.1186/s13063-021-05884-4
Holmdahl V, Gunnarsson U, Strigård K. Autologous full-thickness skin graft as reinforcement in parastomal hernia repair: a randomised controlled trial. Trials. 2021 Dec 07;22(1):891. doi: 10.1186/s13063-021-05884-4. PMID: 34876195; PMCID: PMC8650734.
Copy Download .nbib Format: NLM
Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use.

Gynecological surgery

Diamond MP, Burns EL, Accomando B, Mian S, Holmdahl L.
PMID: 22837733
Gynecol Surg. 2012 Sep;9(3):247-257. doi: 10.1007/s10397-012-0742-8. Epub 2012 Apr 15.

This study seeks to provide a review of the clinical data published as of July 2011 concerning the postsurgical adhesion barrier, Seprafilm (chemically modified hyaluronic acid and carboxymethylcelulose; Genzyme Corporation, Cambridge, MA). Included articles detail the application of Seprafilm...

Cite
Diamond MP, Burns EL, Accomando B, et al. Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use. Gynecol Surg. 2012;9(3):247-257doi: 10.1007/s10397-012-0742-8.
Diamond, M. P., Burns, E. L., Accomando, B., Mian, S., & Holmdahl, L. (2012). Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use. Gynecological surgery, 9(3), 247-257. https://doi.org/10.1007/s10397-012-0742-8
Diamond, Michael P, et al. "Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use." Gynecological surgery vol. 9,3 (2012): 247-257. doi: https://doi.org/10.1007/s10397-012-0742-8
Diamond MP, Burns EL, Accomando B, Mian S, Holmdahl L. Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use. Gynecol Surg. 2012 Sep;9(3):247-257. doi: 10.1007/s10397-012-0742-8. Epub 2012 Apr 15. PMID: 22837733; PMCID: PMC3401301.
Copy Download .nbib Format: NLM
Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor.

Annals of the rheumatic diseases

Ge C, Weisse S, Xu B, Dobritzsch D, Viljanen J, Kihlberg J, Do NN, Schneider N, Lanig H, Holmdahl R, Burkhardt H.
PMID: 35027402
Ann Rheum Dis. 2022 Jan 13; doi: 10.1136/annrheumdis-2021-220500. Epub 2022 Jan 13.

OBJECTIVES: Rheumatoid arthritis (RA) is an autoimmune disease strongly associated with the major histocompatibility complex (MHC) class II allele DRB1*04:01, which encodes a protein that binds self-peptides for presentation to T cells. This study characterises the autoantigen-presenting function of...

Cite
Ge C, Weisse S, Xu B, et al. Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor. Ann Rheum Dis. 2022;doi: 10.1136/annrheumdis-2021-220500.
Ge, C., Weisse, S., Xu, B., Dobritzsch, D., Viljanen, J., Kihlberg, J., Do, N. N., Schneider, N., Lanig, H., Holmdahl, R., & Burkhardt, H. (2022). Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2021-220500
Ge, Changrong, et al. "Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor." Annals of the rheumatic diseases vol. (2022). doi: https://doi.org/10.1136/annrheumdis-2021-220500
Ge C, Weisse S, Xu B, Dobritzsch D, Viljanen J, Kihlberg J, Do NN, Schneider N, Lanig H, Holmdahl R, Burkhardt H. Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor. Ann Rheum Dis. 2022 Jan 13; doi: 10.1136/annrheumdis-2021-220500. Epub 2022 Jan 13. PMID: 35027402.
Copy Download .nbib Format: NLM
Streptococcal Endo-β-.

Frontiers in immunology

Nandakumar KS, Collin M, Happonen KE, Lundström SL, Croxford AM, Xu B, Zubarev RA, Rowley MJ, Blom AM, Kjellman C, Holmdahl R.
PMID: 30061892
Front Immunol. 2018 Jul 16;9:1623. doi: 10.3389/fimmu.2018.01623. eCollection 2018.

Endo-β-

Cite
Nandakumar KS, Collin M, Happonen KE, et al. Streptococcal Endo-β-. Front Immunol. 2018;9:1623doi: 10.3389/fimmu.2018.01623.
Nandakumar, K. S., Collin, M., Happonen, K. E., Lundström, S. L., Croxford, A. M., Xu, B., Zubarev, R. A., Rowley, M. J., Blom, A. M., Kjellman, C., & Holmdahl, R. (2018). Streptococcal Endo-β-. Frontiers in immunology, 91623. https://doi.org/10.3389/fimmu.2018.01623
Nandakumar, Kutty Selva, et al. "Streptococcal Endo-β-." Frontiers in immunology vol. 9 (2018): 1623. doi: https://doi.org/10.3389/fimmu.2018.01623
Nandakumar KS, Collin M, Happonen KE, Lundström SL, Croxford AM, Xu B, Zubarev RA, Rowley MJ, Blom AM, Kjellman C, Holmdahl R. Streptococcal Endo-β-. Front Immunol. 2018 Jul 16;9:1623. doi: 10.3389/fimmu.2018.01623. eCollection 2018. PMID: 30061892; PMCID: PMC6054937.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries